Open access
Open access
Powered by Google Translator Translator

Oncology (all articles)

Review: Management of Cancer-Therapy-Induced LV Dysfunction

2 Nov, 2018 | 03:34h | UTC

Management of Cancer-Therapy-Induced LV Dysfunction: Can the Guidelines Help? – American College of Cardiology (free) (via @md_arianemacedo)

Related: Cardio-Onco-Hematology in Clinical Practice (series of reviews and guidelines on the subject)

 


The Skeptic: What Precision Medicine Revolution?

26 Oct, 2018 | 02:55h | UTC

The skeptic: What precision medicine revolution? – MIT Technology Review (free)

Related: What Precisely Is Precision Oncology—and Will It Work? – The ASCO Post (free)

 


Cohort Study: Angiotensin Converting Enzyme Inhibitors and Risk of Lung Cancer

26 Oct, 2018 | 02:43h | UTC

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study – The BMJ (free)

Editorial: Angiotensin converting enzyme inhibitors and lung cancer (free)

Commentaries: Blood pressure drug linked to possible small increased risk of lung cancer – NHS Choices (free) AND Expert reaction to study looking at blood pressure drugs and lung cancer risk – Science Media Centre (free)

 


Organic Foods for Cancer Prevention??

26 Oct, 2018 | 02:04h | UTC

Association of Frequency of Organic Food Consumption With Cancer Risk: Findings From the NutriNet-Santé Prospective Cohort Study – JAMA Internal Medicine (free for a limited period)

Commentaries: Organic Foods for Cancer Prevention—Worth the Investment? – JAMA Internal Medicine (free for a limited period) AND Organic food and cancer – Science Media Centre (free) AND Organic foods tied to slightly lower cancer risk – Reuters (free)

 


Randomized Trial: Treatments of Advanced Triple-Negative Breast Cancer Compaired

26 Oct, 2018 | 02:03h | UTC

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer – New England Journal of Medicine (free for a limited period)

Commentaries: Not So Fast With Immune Therapy For Breast Cancer – Forbes (free) AND Immunotherapy drugs show some promise against breast cancer – STAT (free)

“…the benefit for most women was small, raising questions about whether the treatment is worth its high cost and side effects.” (from STAT)

 


Randomized Trial: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer

26 Oct, 2018 | 01:45h | UTC

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial – The Lancet (free)

Commentaries: Radiotherapy for newly diagnosed oligometastatic prostate cancer – The Lancet (free) AND ESMO 2018: Local radiotherapy improves survival in metastatic prostate cancer with low disease burden – eCancer News (free) AND Radiotherapy offers hopes in advanced prostate cancer – OnMedica (free) AND Cancer trial shows treating the prostate with radiotherapy improves survival – University of Birmingham (free)

 


NCCN Guideline: Small Cell Lung Cancer

17 Oct, 2018 | 13:42h | UTC

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. – Journal of the National Comprehensive Cancer Network (free)

 


NCCN Survivorship Care Guideline 2018

17 Oct, 2018 | 13:36h | UTC

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network (free)

Related: Cardiovascular Toxicity in Cancer Survivors (free review and guidelines) AND Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors (link to abstract and commentaries) AND The cumulative burden of surviving childhood cancer (link to abstract and commentaries) AND Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood (free study and commentaries) AND Endocrine Disorders in Survivors of Childhood Cancer (free guideline and commentaries)

 


Study: Deep Learning to Distinguish False-Positive Mammograms

16 Oct, 2018 | 23:29h | UTC

Deep Learning to Distinguish Recalled but Benign Mammography Images in Breast Cancer Screening – Clinical Cancer Research (link to abstract – $ for full-text)

Commentaries: AI distinguishes false-positive mammograms from malignant, negative mammograms – Radiology Business (free) AND Deep learning can distinguish recalled-benign mammograms from malignant and negative images – eCancer News (free)

 


Guideline: Hypofractionated Radiation Therapy for Localized Prostate Cancer

16 Oct, 2018 | 23:28h | UTC

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline – Journal of Clinical Oncology (free)

News Release: New ASTRO/ASCO/AUA Guideline for Early-Stage Prostate Cancer Supports Use of Shortened Courses of Radiation Therapy (free)

 


Study: Classification and Personalized Prognosis in Myeloproliferative Neoplasms

16 Oct, 2018 | 23:27h | UTC

Classification and Personalized Prognosis in Myeloproliferative Neoplasms – New England Journal of Medicine (free for a limited period)

 


A Blueprint for the Primary Prevention of Cancer

16 Oct, 2018 | 23:14h | UTC

A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors – CA: A Cancer Journal for Clinicians (free)

Commentary: Comprehensive report says tobacco control must be highest priority in cancer control – American Cancer Society (free)

 


Review: Cancer-Associated Thrombosis

16 Oct, 2018 | 21:45h | UTC

Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment – Cancers (free)

 


Review: Primary Central Nervous System Lymphoma

16 Oct, 2018 | 21:38h | UTC

Primary central nervous system lymphoma – Therapeutic Advances in Neurologic Diseases (free)

 


Study: Screening with Breast Tomosynthesis vs. Mammography

16 Oct, 2018 | 21:25h | UTC

One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: 3D mammography detected 34% more breast cancers in screening – Lund University (free)

 


Consensus Statement: Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies

12 Oct, 2018 | 01:42h | UTC

Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology – Clinical and Translational Oncology (free)

 


Last Month in Oncology with Dr. Bishal Gyawali: September 2018

11 Oct, 2018 | 21:33h | UTC

Last Month in Oncology with Dr. Bishal Gyawali: September 2018 – eCancer News (free)

 


ESMO Updated Clinical Practice Guidelines

11 Oct, 2018 | 20:12h | UTC

Supplement: ESMO Updated Clinical Practice Guidelines – European Society of Medical Oncology (free)

 


Study: Incidence of Progression of Persistent Non-Dysplastic Barrett’s Esophagus to Malignancy

11 Oct, 2018 | 20:01h | UTC

Incidence of Progression of Persistent Non-Dysplastic Barrett’s Esophagus to Malignancy – Clinical Gastroenterology and Hepatology (link to abstract – $ for full-text)

Commentary: Patients with stable Barrett’s esophagus may need less surveillance, study finds – ACP Gastroenterology (free)

 


Clinical Update: Immune Checkpoint Inhibitor Toxicity in 2018

5 Oct, 2018 | 02:42h | UTC

Immune Checkpoint Inhibitor Toxicity in 2018 – JAMA (free for a limited period)

Related Guidelines: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (free) AND Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group (free)

Related Review: New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management – Critical Care (free)

 


Study: The Projected Timeframe Until Cervical Cancer Elimination in Australia

5 Oct, 2018 | 02:31h | UTC

The projected timeframe until cervical cancer elimination in Australia: a modelling study – The Lancet Public Health (free)

Commentaries: Modelling cervical cancer elimination – The Lancet Public Health (free) AND Australia on track to wipe out cervical cancer within 20 years – The Guardian (free) AND In Australia, Cervical Cancer Could Soon Be Eliminated – The New York Times (10 articles per month are free)

 


Study: Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology

5 Oct, 2018 | 02:26h | UTC

Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentaries: Health-related quality of life overlooked in cancer drug studies – McMaster University (free) AND Investigators Question the Use of PFS as a Surrogate End Point – Cancer Therapy Advisor (free) AND Preventing tumor spread may not improve quality of life – Reuters (free) AND Research: Consider quality of life when evaluating cancer drug studies – UPI (free)

 


Guideline: Management of Malignant Pleural Effusions

5 Oct, 2018 | 02:21h | UTC

Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine (free)

Related Guideline: ERS/EACTS statement on the management of malignant pleural effusions – European Respiratory Journal (free)

 


The Nobel Prize in Physiology or Medicine 2018

5 Oct, 2018 | 01:58h | UTC

Press Release: The Nobel Prize in Physiology or Medicine 2018 – The Nobel Prize (free)

Commentaries: Cancer immunologists scoop medicine Nobel prize – Nature (free) AND Nobel Prize in medicine awarded to two cancer researchers for immune system breakthrough – STAT (free) AND 2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers – The New York Times (10 articles per month are free)

 


Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality

5 Oct, 2018 | 01:31h | UTC

WCLC 2018: NELSON Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality – The ASCO Post (free)

Related: NELSON lung cancer study encourages widespread screening, Medicare reimbursement – Health Imaging (free) AND Second Large Study Shows That Lung Cancer Screening Works – Medscape (free registration required)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.